Search Results

UCSF Helen Diller Family Comprehensive Cancer Center Use of electronic cigarettes costs the United States $15 billion annually in health care expenditures—more than $2,000 per person a year—according to a study by researchers at UCSF. Findings indicate health care costs are $2,000 per year higher among people who vape compared to non-tobacco users. The study is the first to look at the health care costs of e-cigarette use among adults 18 and older. Read More

Sylvester Comprehensive Cancer Center, University of Miami Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and Moffitt Cancer Center have used whole genome sequencing (WGS) to identify mutations that make B-cell lymphomas resistant to CAR T immunotherapies. These findings highlight the importance of WGS to comprehensively map resistance mutations and chromosomal damage. Read More

Cedars-Sinai Cancer A first-of-its-kind LGBTQ+ cancer symposium is part of Cedars-Sinai's effort to equalize healthcare access and treatment for all – including patients who identify as LGBTQ+. Studies have shown that the way LGBTQ+ patients are screened, diagnosed, and treated for cancer may put them at a significant disadvantage compared to cisgender heterosexual patients. Read More

University of Michigan Rogel Cancer Center In early research led by the University of Michigan Health Rogel Cancer Center, the oral medication zanubrutinib was found to help most patients with a slow-growing type of cancer known as marginal zone lymphoma. Read More

The AACI Clinical Research Innovation (CRI) Steering Committee, with the assistance of peer reviewers from CRI committees, have selected three abstracts from 73 submissions for formal presentation on Wednesday, July 13, at the 14th Annual AACI CRI Meeting. Winning abstract authors represent Sylvester Comprehensive Cancer Center, University of Miami Health System; University of Florida Health Cancer Center; and Mayo Clinic Cancer Center. Read More

The University of Kansas Cancer Center People undergoing active cancer treatment, including stem cell transplant, should receive the COVID-19 vaccine, according to a new study. People with cancer are at a higher risk of developing severe COVID-19 and dying from it. These findings provide guidance to a group largely excluded from clinical trials evaluating the efficacy of COVID-19 vaccines. Qamar Khan, MD, led the study. Read More

Laura and Isaac Perlmutter Cancer Center at NYU Langone In the presence of pancreatic tumors, certain immune cells break down structural proteins into molecules that trigger the building of dense tissue, a known barrier to therapy, a new study finds. Led by researchers from NYU Grossman School of Medicine, the study revolves around the dense protein meshwork that supports organs and helps to rebuild damaged tissue. Read More

Montefiore Einstein Comprehensive Cancer Center In a recent study, investigators at Montefiore Einstein Cancer Center report that Black and Hispanic patients had outcomes and side effects following CAR T treatment that were comparable to their white and Asian counterparts. Read More

Vanderbilt-Ingram Cancer Center Eden Biltibo, MD, has been selected for the 2022 ASH-CIBMTR-ASTCT Career Development Award. The award is part of the ASH Minority Hematology Fellow Award program, which supports early-career researchers from minority groups historically underrepresented in medicine. Read More

The 2022 AACI/AACR Hill Day is scheduled for Wednesday, June 15. All faculty and staff of AACI cancer centers and AACR members are invited to spend the day advocating for cancer research funding through virtual meetings. Hill Day registration closes this Friday, June 3. Read More

Yale Cancer Center, Yale School of Medicine Scientists at Yale Cancer Center have found that patients with breast cancer and high levels of insulin in the blood may be responsive to metabolism-targeting treatments, which in turn may improve the effectiveness of subsequent chemotherapy treatments. Read More

Fox Chase Cancer Center, Temple Health The Pennsylvania Medical Society has announced its 2022 Top Physicians Under 40 award recipients. Two Fox Chase Cancer Center doctors were honored: Kristen Manley, MD, and Jason Castellanos, MD, MS. Read More

Fred Hutchinson Cancer Center Fred Hutchinson Cancer Research Center immunologist Philip Greenberg, MD, has begun a year-long term as president-elect of the American Association for Cancer Research (AACR), setting the stage for him to lead the organization as president in 2023. Read More

UCLA Jonsson Comprehensive Cancer Center The UCLA Jonsson Comprehensive Cancer has named Beth Glenn, PhD, co-director of its Cancer Control and Survivorship research program. Dr. Glenn is a professor in the UCLA Fielding School of Public Health and associate director of the UCLA Kaiser Permanente Center for Health Equity. She will join the research program's director, Patricia Ganz, MD, and co-director Roshan Bastani, PhD. Read More

AACI's Board of Directors, staff, and cancer center leaders firmly believe that the epidemic of gun violence must be confronted with a sense of urgency – just as we address cancer, COVID-19, and other crises that impact public health. As an association comprised of 104 academic and freestanding cancer centers across the United States and in Canada, AACI is committed to reducing the burden of cancer through research, treatment, and advocacy. In our role as advocates, it is our duty to seek ways …

UMMC Cancer Center and Research Institute Masood Muhammad Hassan, MD, has joined the University of Mississippi Medical Center as an assistant professor of pathology. At UMMC, he is a member of the Cancer Center and Research Institute Interdisciplinary Breast Cancer Care team as well as conducting cancer research. Read More

"The Patient Resource guides improve and extend referring provider relationships while providing them confidence in their referral decisions." – Lina Wilson, Physician Relations, The University of Kansas Health System "Based on this guide alone, if I had a friend with cancer, I’d recommend they come here so they would get this educational piece." – Participant, Patient Focus Group For more information, contact Amy Galey. Learn More

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center The University of Maryland Medical Center has broken ground for a $219 million, nine-story patient care tower—the Roslyn and Leonard Stoler Center for Advanced Medicine—that will become the new home of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center. Kevin J. Cullen, MD, is the center's director. Read More

Memorial Sloan Kettering Cancer Center A small clinical trial conducted by Memorial Sloan Kettering Cancer Center found that every rectal cancer patient who received an experimental immunotherapy treatment had their cancer go into remission. Read More

National Cancer Institute The Cancer Grand Challenges program, funded by the National Cancer Institute and Cancer Research UK, will award $100 million to four interdisciplinary teams from around the world to solve some of the toughest challenges in cancer research. Each team will receive $25 million over five years. The teams include researchers from a number of AACI cancer centers. Read More

Huntsman Cancer Institute at the University of Utah Huntsman Cancer Institute at the University of Utah announces a formal expansion of its catchment area. In addition to Utah, it now includes Idaho, Montana, Nevada, and Wyoming. Neli Ulrich, PhD, MS, is the center's executive director. Read More

Sylvester Comprehensive Cancer Center, University of Miami Sylvester Comprehensive Cancer Center is celebrating the groundbreaking for a 244,000-square-foot, state-of-the-art Sylvester Comprehensive Cancer Center - Transformational Cancer Research Building. The 12-story facility is slated to open in 2024. Read More

A national search for a director for the Louisiana Cancer Research Center (LCRC) has culminated in the selection of cancer biology researcher Joe W. Ramos, PhD. Dr. Ramos is currently the interim director of the University of Hawai'i Cancer Center. He will be officially introduced as director and chief executive officer of the LCRC on July 26 and will begin a tour of research institutions in the state that week. Read More

UAMS Winthrop P. Rockefeller Cancer Institute The UAMS Winthrop P. Rockefeller Cancer Institute is implementing a new statewide patient navigation program to help cancer patients across the state access needed prevention, screening, treatment and support services. Read More

Simmons Comprehensive Cancer Center, UT Southwestern Medical Center An estimated one-quarter of adults in the U.S. have nonalcoholic fatty liver disease (NAFLD), an excess of fat in liver cells that can increase the risk of liver cancer. Now, UT Southwestern researchers have developed a simple blood test to predict which NAFLD patients are most likely to develop liver cancer. Read More

Mayo Clinic Comprehensive Cancer Center Three Mayo Clinic Cancer Center leaders have assumed new roles: Stephen M. Ansell, MD, PhD, has been named enterprise deputy director and senior deputy director, Midwest; Roxana Dronca, MD, has been named director, Florida Cancer Programs; and Alan Bryce, MD, will serve as acting director, Arizona Cancer Programs. Pictured, clockwise from top right: Stephen M. Ansell, MD, PhD; Roxana Dronca, MD; and Alan Bryce, MD Read More

Pavan Reddy, MD, is joining Baylor College of Medicine as director of the Dan L Duncan Comprehensive Cancer Center. He will lead oncology services, research, and strategic growth at Baylor St. Luke’s Medical Center. Dr. Reddy joins Baylor after more than 20 years at the University of Michigan. Read More

Selwyn M. Vickers, MD, FACS, a pancreatic cancer surgeon and researcher and pioneer in cancer health disparities research, has been selected to serve as the next president and chief executive officer of Memorial Sloan Kettering Cancer Center. He will succeed Craig B. Thompson, MD, who announced his intention to step down earlier this year. The transition will occur in September 2022. Read More

Wilmot Cancer Institute, UR Medicine Carlos Ortiz-Bonilla, a Puerto Rican native who has been studying science at the University of Rochester (UR) for the past seven years, is the first graduate of a new course concentration in cancer biology, spearheaded by the Wilmot Cancer Institute. The cancer biology concentration was developed in partnership with UR's doctoral programs. Read More

Sidney Kimmel Cancer Center at Jefferson Health Cancer screening guidelines published last year expand eligibility for those at high risk for lung cancer, and new research shows that they also improve representation among African American patients. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University A novel, automated liquid biopsy test in development by researchers at the Johns Hopkins Kimmel Cancer Center can accurately detect the presence of cancer DNA in the blood of patients with metastatic breast cancer within five hours. Read More

Winship Cancer Institute of Emory University Winship Cancer Institute of Emory University has been awarded an $11 million grant from the National Cancer Institute to support research aimed at improving the effectiveness of immunotherapy for lung cancer in patients with a mutation of the LKB1 gene. The research is led by Haian Fu, PhD, and Suresh Ramalingam, MD. Read More

Vanderbilt-Ingram Cancer Center A $10 million gift from the Brock family will establish the Brock Family Center for Applied Innovation at Vanderbilt University Medical Center. The gift will accelerate translation of discoveries through commercialization and industry partnerships. John Brock III is the retired CEO of Coca-Cola European Partners PLC, formerly Atlanta-based Coca-Cola Enterprises, Inc. Read More

Fox Chase Cancer Center, Temple Health Sameer Patel, MD, FACS, chief of the Division of Plastic & Reconstructive Surgery at Fox Chase Cancer Center, was recently inducted into the American Association of Plastic Surgeons. Read More

Fred Hutchinson Cancer Center An unexpected trick in cancer’s playbook may fool an important component of our immune systems into knocking down our natural defenses against solid tumors. Scientists at Fred Hutchinson Cancer Research Center say this newfound vulnerability involves a misuse of a type of T cell, part of a large family of blood cells that are essential to a functioning immune system. Read More

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute New data show that ammonia—typically known as a waste byproduct from protein degradation that is excreted from the human body through urine—plays a key role in fueling the rapid growth of certain aggressive forms of cancer. Read More

UPMC Hillman Cancer Center Heath D. Skinner, MD, PhD, has been appointed chair of the Department of Radiation Oncology, effective July 1. Clinically, he will focus on advancing UPMC Hillman Cancer Center’s radiation oncology services nationally and enhancing access to care. Read More

Moffitt Cancer Center In a new study, Moffitt Cancer Center researchers report on their identification of biomarkers based on a type of genetic modification called methylation that predicts the type of tumor immune environment and patient outcomes. Read More

Cedars-Sinai Cancer Male sex hormones interfere with the body’s ability to fight bladder cancer, likely explaining why males experience higher cancer rates and more deadly disease, according to a new study co-led by a Cedars-Sinai Cancer investigator. Read More

Stony Brook Cancer Center A team of scientists from Stony Brook Cancer Center and Renaissance School of Medicine at Stony Brook University believe they have found a new process through which drug resistance happens. A computer simulation model is helping them understand how molecules interact with Imatinib in the chemotherapy resistant process. Read More

The University of Texas MD Anderson Cancer Center Androgen receptor signaling affects response to BRAF/MEK inhibitor therapy in both males and females with melanoma, researchers from MD Anderson Cancer Center showed in a new study. The findings provide a new target to combat therapeutic resistance and one possible answer to why men face a poorer prognosis than women when diagnosed with melanoma. Read More

On June 15, AACI jointly hosted the 2022 virtual Hill Day with the American Association for Cancer Research (AACR). During meetings with legislators, cancer center directors, researchers, physician-scientists, cancer survivors, and other advocates made the case for robust, sustained federal investments in biomedical research—and cancer research in particular—through the National Institutes of Health (NIH) and the National Cancer Institute (NCI). Read More

Duke Cancer Institute, Duke University Medical Center After losing a close friend to acute myeloid leukemia, Kris Wood, PhD, devoted his research to helping find better treatment options for people with leukemias and lymphomas. He and his colleagues have discovered a potential new drug therapy that is preparing to enter clinical trials. Read More

The Tisch Cancer Institute at Mount Sinai Mount Sinai researchers have validated for the first time that a liquid biopsy could be a better predictor of whether cancer immunotherapy will be successful for a patient with lung cancer than an invasive tumor biopsy. Read More

Fox Chase Cancer Center, Temple Health Laura Bukavina, MD, MPH, has been awarded a 2022 Urology Care Foundation Research Scholar Award, which supports future research leaders and ensures they receive the necessary training and guidance for a successful research career. The Urology Care Foundation is the official foundation of the American Urological Association. Read More

Stony Brook Cancer Center A study of the lead agent (CPI-613) in a class of anticancer drugs undergoing U.S. Food and Drug Administration approved clinical trials reveals that CPI-613 is effective against most carcinoma cell lines, and, used in combination, could have efficacy against reducing some tumors. The research was led by Paul M. Bingham, PhD. Read More

University of Colorado Cancer Center For Sharon Pine, PhD, racial and economic disparities in cancer diagnosis and care add an urgency to lung cancer research. Dr. Pine will bring that motivation to her new role as director of the Thoracic Oncology Research Initiative (TORI) at the University of Colorado Cancer Center. Read More

The University of Kansas Cancer Center The University of Kansas Cancer Center researchers have released the results of a clinical trial that examined the effectiveness of varenicline in African Americans. In their study, African American daily smokers who were given varenicline while receiving counseling had significantly greater quit rates than those who received a placebo. Read More

Duke Cancer Institute, Duke University Medical Center A Duke Cancer Institute study led by Gayathri Devi, PhD, finds chronic stresses such as racism and poverty alter cellular functions that promote tumor growth and proliferation. Read More

Roswell Park Comprehensive Cancer Center A team of researchers at Roswell Park, led by Dhyan Chandra, PhD, have uncovered evidence that could lead to the development of a new treatment option for patients with metastatic, resistant or recurrent prostate cancer. Their findings suggest that mitochondrial unfolded protein response could be a new target for the treatment and management of this patient population. Read More

Sidney Kimmel Cancer Center at Jefferson Health New research shows in an animal model that using viral and bacterial vaccine approaches together is safe and far more effective at fighting treatment-resistant cancer than either approach by itself. Read More

The Jackson Laboratory Cancer Center The Glioma Longitudinal Analysis Consortium (GLASS) is investigating why gliomas develop resistance and recur. By analyzing tumor samples from patients before treatment then after recurrence, GLASS scientists, led by Roel Verhaak, PhD, are discovering how the brain tissue environment and the therapies themselves drive glioma cell changes that allow them to adapt and grow again. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University New laboratory research directed by investigators at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins Bloomberg School of Public Health finds that secreted age-induced changes in distant sites such as the lung can effectively reactivate dormant cells and cause them to grow. Read More

Roswell Park Comprehensive Cancer Center A research leader with a record of important discoveries in cancer biology and precision therapeutics, Roswell Park’s Erik Knudsen, PhD, has been promoted to associate director of basic science research. Read More

Winship Cancer Institute of Emory University Stacy L. Palmer, MBA, has joined Winship Cancer Institute of Emory University as the new vice president of cancer clinical administration and strategy. She will be responsible for coordinating clinical strategy and supporting standardization of cancer care across clinical sites and partners. Read More

Mayo Clinic Comprehensive Cancer Center Mayo Clinic Cancer Center has announced a new community outreach and engagement (COE) leadership team to help develop targeted interventions that will lead to sustainable, impactful changes in health equity. Read More

Cedars-Sinai Cancer Experts from Cedars-Sinai Cancer have analyzed patient samples, along with studies conducted in animal models, to identify a novel immune checkpoint pathway to treat hepatocellular carcinoma. The findings are centered on the discovery of a novel role for the IL-27 signaling pathway in liver cancer. Read More

UCSF Helen Diller Family Comprehensive Cancer Center A new study led by Joel Palefsky, MD, found that routine screening for and removal of precancerous anal lesions can significantly reduce the risk of anal cancer, similar to the way cervical cancer is prevented in women. Read More

The University of Texas MD Anderson Cancer Center In a Phase II clinical trial, immune checkpoint blockade before surgery was associated with favorable responses and outcomes in undifferentiated pleomorphic sarcoma and recurrent dedifferentiated liposarcoma, researchers from The University of Texas MD Anderson Cancer Center have reported. Read More

The Tisch Cancer Institute at Mount Sinai Researchers at the Icahn School of Medicine at Mount Sinai found that an advanced radiotherapy technique called radiation segmentectomy may be effective against very early to early-stage hepatocellular carcinoma (HCC). It is the first prospective study to explore the efficacy and outcomes of this technique. Results suggest it may be a curative treatment for inoperable, early-stage HCC. Read More

WVU Cancer Institute Edward Harrison has joined the WVU Cancer Institute as its vice president of cancer services. His first day on the job was May 16. Prior to WVU, he served in various leadership roles at UPMC and the University of Pittsburgh. Read More

University of Colorado Cancer Center With more than 20 years of experience in gene therapy and personalized medicine, Hatim Sabaawy, MD, PhD, steps into the role of associate director of translational research at the University of Colorado (CU) Cancer Center on July 1. Dr. Sabaawy joins CU from Rutgers University in New Jersey. Read More

UK Markey Cancer Center The UK Markey Cancer Center has received a $5 million gift to establish the Ambassador William Stamps Farish Program of Excellence in Urologic Cancer. Read More

Moffitt Cancer Center Moffitt Cancer Center researchers have revealed a mechanism by which prostate cancer cells become resistant through molecular modification of the androgen receptor protein and identify a potential treatment approach that could overcome this resistance. Read More

Laura and Isaac Perlmutter Cancer Center at NYU Langone A team of New York City lung cancer experts, led by investigators at NYU Langone Health's Perlmutter Cancer Center, have received a three-year, $1 million grant from Stand Up To Cancer® (SU2C) to bring technology-enabled immunotherapy monitoring to under-represented patient populations. Read More

Registration at the regular rate begins today for the 2022 AACI/CCAF Annual Meeting, which will take place October 2-4 at InterContinental at the Plaza, Kansas City, MO. There is still time to register for the 14th Annual AACI Clinical Research Innovation (CRI) Meeting, which will be held July 12-14 at the Loews Chicago O'Hare Hotel in Rosemont, IL. Read More

AACI will host its inaugural Leadership Diversity and Development Initiative (LDDI) Workshop, November 8-9, at the Loews Chicago O'Hare Hotel in Rosemont, IL. The pilot event will convene emerging leaders from each AACI member cancer center at in-depth leadership development workshops. LDDI workshops are part of the presidential initiative of AACI President Caryn Lerman, PhD, director of USC Norris Comprehensive Cancer Center. Read More

The June 24 Supreme Court decision on Dobbs v. Jackson reversed the 1973 ruling on Roe v. Wade, allowing individual states to determine access to abortion. As state leaders weigh the implications of the Supreme Court decision, AACI urges them to consider its ripple effects on access to quality cancer prevention, screening, and treatment services, particularly as they impact communities of color, sexual and gender minorities, residents of rural communities, and other groups that experience cance…

The AACI Board of Directors has selected the recipients of the 2022 Distinguished Scientist, Cancer Health Equity, and Champion for Cures Awards. The awards will be presented in person on Monday, October 3, during the 2022 AACI/CCAF Annual Meeting in Kansas City, MO. Congratulations to this year's honorees! Pictured, clockwise from top left: Dr. Elizabeth Jaffee (Distinguished Scientist), Dr. Electra Paskett (Cancer Health Equity), and Pelotonia (Champion for Cures) Read More

Rutgers Cancer Institute of New Jersey Coral Omene, MD, PhD, medical oncologist in the Stacy Goldstein Breast Cancer Center at Rutgers Cancer Institute of New Jersey, has been awarded a grant from the V Foundation for Cancer Research in partnership with ESPN to increase clinical trial awareness and enrollment of Black women with breast cancer. Read More

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute The Ohio State University Wexner Medical Center has selected Chyke A. Doubeni, MBBS, MPH, to serve as chief health equity officer and lead the Office of Health Equity, Diversity and Inclusion. He joins Ohio State from Mayo Clinic, where he is the director of the Mayo Clinic Center for Health Equity and Community Engagement Research. Read More

The University of Kansas Cancer Center The University of Kansas Cancer Center (KUCC) has been designated a "Comprehensive" cancer center – the highest level of recognition award by the National Cancer Institute (NCI). The designation includes a five-year, $13.8 million grant to support the center’s research programs, shared equipment, and resources. KUCC also received an "outstanding" rating by NCI reviewers. AACI Immediate Past President Roy A. Jensen, MD, is director. Read More

UK Markey Cancer Center Kentucky has established a lung cancer screening program, supported by the Kentucky Cancer Consortium (KCC) Lung Cancer Network—with over 100 organizations—and the Kentucky LEADS(Lung Cancer Education Awareness Detection Survivorship) Collaborative, both housed at UK Markey Cancer Center. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Surveillance programs for people at high risk of developing pancreatic cancers can help detect precancerous conditions and cancers early, when they are most treatable, according to a new multicenter study directed by experts at the Johns Hopkins Kimmel Cancer Center. Read More

Registration is now open for AACI’s new Leadership Diversity and Development Initiative (LDDI) Workshop, which will be held November 8-9 at Loews Chicago O’Hare Hotel. The event will convene a diverse group of emerging leaders from AACI cancer centers with both didactic and experiential leadership development sessions over 1.5 days. Each AACI cancer center director may select one emerging leader from their center to attend. The selected participants should represent diverse backgrounds, perspec…

Cancer Center at Illinois Developed by Cancer Center at Illinois scientists, an innovative camera technology recently led to a $9 million award from the National Cancer Institute in which researchers at the University of Pennsylvania, Purdue University, and Johnson & Johnson are collaborating on innovations that synergize with the camera technology and leading clinical trials with lung cancer patients at Penn Medicine. Read More

University of Michigan Rogel Cancer Center A team of researchers at the University of Michigan Rogel Cancer Center were the first to generate a bona fide mouse model of a Merkel cell carcinoma. A Merkel cell polyomavirus is believed to cause about 80 percent of these tumors, but researchers have been unable to definitively show this in vivo. Read More

Stony Brook Cancer Center A study that surveyed cancer screening data included in medical journals worldwide from January 2020 into December 2021 showed significant decreases in the number of screenings for breast, colorectal, and cervical cancers during the early phase of the COVID-19 pandemic. Paolo Boffetta, MD, MPH, is the study's lead author. Read More

In 2021, AACI surveyed members on diversity in cancer center leadership. A group led by Caryn Lerman, PhD, AACI president and director of USC Norris Comprehensive Cancer Center, shared the results of this study in "Leadership Diversity and Development in the Nation’s Cancer Centers," published last month in the Journal of the National Cancer Institute. Read More

The AACI Clinical Research Innovation (CRI) Steering Committee is seeking nominations. The CRI Steering Committee helps guide and implement activities to disseminate best practices across AACI cancer center clinical trials offices. The current steering committee members will vote, and one (1) chair-elect and three (3) new members will be added to the steering committee. Read More

Moffitt Cancer Center Turnstone Biologics Corp. and Moffitt Cancer Center have announced the formation of a broad strategic alliance, deepening their existing multi-year research collaboration. As part of this expanded partnership, Turnstone will have priority access to Moffitt’s scientific research, manufacturing, and clinical capabilities for the development of novel tumor infiltrating lymphocyte ("TIL") therapies. Read More

The University of Texas MD Anderson Cancer Center The University of Texas MD Anderson Cancer Center has announced Kimberly Hoggatt Krumwiede, PhD, as dean of MD Anderson’s School of Health Professions, effective August 1. Read More

Duke Cancer Institute, Duke University Medical Center The National Institutes of Health (NIH) Heart, Lung and Blood Institute has awarded a $3 million grant to Atrium Health Wake Forest Baptist Comprehensive Cancer Center, VCU Massey Cancer Center, and Duke Cancer Institute to collaborate in a first-of-its-kind prospective study about the long-term heart health of young breast cancer survivors. Read More

The Tisch Cancer Institute at Mount Sinai The Office of Cancer Clinical Proteomics Research at the National Cancer Institute (NCI) has awarded $4.2 million over five years to Mount Sinai researchers establishing a Proteogenomic Data Analysis Center to advance cancer research and treatments. Read More

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Data collected by researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy suggest that Clostridioides difficile, or C. diff, a bacterial species well known for causing serious diarrheal infections, may also drive colorectal cancer. Read More

Cedars-Sinai Cancer Howard Sandler, MD, chair of the Department of Radiation Oncology at Cedars-Sinai Cancer, has been named president-elect of the American Society for Radiation Oncology (ASTRO). He will begin his term as president-elect in October, followed by single-year terms as president, chair, and immediate past chair of the ASTRO board. Read More

University of New Mexico Comprehensive Cancer Center Clinical trials form the backbone of the care provided at UNM Comprehensive Cancer Center. "At the end of the day, everything we do that is standard of care at one point was a clinical trial," said Cheryl Sampson, MBA, recently hired director of the center's clinical research office and executive director of the New Mexico Cancer Research Alliance. Read More

University of Michigan Rogel Cancer Center University of Michigan and Rogel Cancer Center researchers have discovered brain tumors contain highly active cells that move throughout tissue in complicated patterns. What’s more, the accumulations of these elongated, spindle-like cells found throughout the tumor, coined "oncostreams," serve as the basis for cancerous cells’ behavior, determining how tumors grow and invade normal tissue. Read More

Winship Cancer Institute of Emory University A new study conducted by Winship Cancer Institute finds that COVID-19 vaccines are much less effective for patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia (NHL/CLL), particularly those age 65 and older. After vaccination, many of these patients produced low or no antibodies that bind or neutralize SARS-CoV-2 and its variants of concern, especially Omicron. Read More

Cedars-Sinai Cancer Marc Botnick, MD, has been named regional medical director for radiation oncology at Cedars-Sinai Cancer. His primary clinical practice site will be at Cedars-Sinai Tarzana Radiation Oncology, but he will work closely with physicians throughout the enterprise. Read More

Fox Chase Cancer Center, Temple Health Researchers at Fox Chase Cancer Center have been awarded a Department of Defense Prostate Cancer Health Disparity Research Award for New Investigators. The three-year, $1.4-million grant provides funding to investigate how social determinants of health, including environment and socioeconomic status, impact quality of life and treatment-related decision-making in men with advanced prostate cancer. Read More

Vanderbilt-Ingram Cancer Center Vanderbilt University Medical Center and the University of Zambia are partnering on a program to develop a cadre of researchers and educators to lead cancer epidemiology research and training in Zambia and to encourage U.S.-based researchers to engage in cancer research in low- and middle-income countries. The program is supported by a $1.3 million National Cancer Institute grant. Read More

UK Markey Cancer Center The UK Markey Cancer Center’s Community Impact Office recently launched Cancer InFocus: Kentucky – a new, online data mapping application that allows users to explore cancer incidence and mortality data alongside population demographics, social determinants of health, and behavioral risk factors at various geographic levels across the Commonwealth. Read More

Yale Cancer Center, Yale School of Medicine Although there has been a significant increase in the number of U.S. residents insured through Medicaid since the expansion of the Patient Protection and Affordable Care Act (ACA) in March 2010, the ability of Medicaid-insured patients to access cancer care services has not been well understood. In a recently published study, researchers at Yale Cancer Center assessed the acceptance of Medicaid insurance among patients diagnosed with common can…

Simmons Comprehensive Cancer Center, UT Southwestern Medical Center UT Southwestern is joining with medical centers around the nation to apply advanced sequencing to pediatric brain tumors as part of the National Cancer Institute’s new Molecular Characterization Initiative, a subset of the Cancer Moonshot Childhood Cancer Initiative. Read More

UCSF Helen Diller Family Comprehensive Cancer Center The Cancer Research Institute announced two UCSF investigators in the newest cohort of scientists chosen for the Lloyd J. Old STAR Program (Scientists Taking Risks). Each STAR will receive a grant of $1.25 million payable over five years to carry out high-risk/high-reward research that has the potential to produce transformative leaps forward in tumor immunology. Read More

UCLA Jonsson Comprehensive Cancer Center UCLA Health’s Ahmanson Translational Theranostics Division has been designated a Comprehensive Radiopharmaceutical Therapy Center of Excellence by the Society of Nuclear Medicine & Molecular Imaging. Read More

Winship Cancer Institute of Emory University In an investigator-sponsored study, 91 percent of participants with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) experienced clinical benefit in a Phase II trial testing a combination of the tyrosine kinase inhibitor cabozantinib, with the immune check point inhibitor in pembrolizumab. Read More